Biblio Discovery — Demo Discovery Service

14 results for "Behrooz Ghezelbash"

Showing 1–14 · 1.35 seconds · RSS

  1. Journal Article

    Challenges of Establishing a National Rare Donor Program in Iran

    Behrooz Ghezelbash; Mostafa Moghaddam; Sima Aghazadeh

    International Journal of Hematology-Oncology and Stem Cell Research, Vol. 12 No. 3 · 2018 · English · DOAJ Scopus

    Background: Over the past decades, interest in establishing a National Rare Donor Program has increased significantly worldwide. The experience of developing countries, however, is still limited. Rare blood is defined as a blood group found in a 1000- 5000 population and donor has an absence of a…

  2. Journal Article

    Evaluation of Alloimmunization Rate and Necessity of Blood Type and Screening Test among Patients Candidate for Elective Surgery

    Ahmad Gharehbaghian; Behrooz Ghezelbash; Sima Aghazade et al.

    International Journal of Hematology-Oncology and Stem Cell Research, Vol. 8 No. 1 · 2014 · English · DOAJ Scopus

    Introduction: Alloimmunization is a reaction of the immune system to foreign antigens. For prevention of alloantibody formation, performing of type and screen test is necessary on a patient's blood specimen as part of pre-transfusion testing. Materials and method: In this cross-sectional study…

  3. Journal Article

    The Effects of Glutathione Monoethyl Ester on Different Biochemical, Oxidant, and Antioxidant Levels During Storage in Leukoreduced Red Blood Cells

    Behrooz Ghezelbash; Mohammadreza Deyhim; Azita Azarkeivan et al.

    Advanced Biomedical Research, Vol. 13 No. 1 · 2024 · English · DOAJ Scopus

    Background: It is essential to maintain the quality of the stored blood, because various factors affect the stored red blood cells (RBCs) over time, some red blood cell storage lesions (RCSL) develop during storage, and it could reduce the function of the RBCs. The present study aimed to evaluate…

  4. Journal Article

    Correlation of Expression of MMP-2, ACE2, and TMPRSS2 Genes with Lymphopenia for Mild and Severity of COVID-19

    Behrooz Ghezelbash; Mehdi Rostami; Mohammad Heidarvand et al.

    Iranian Journal of Allergy, Asthma and Immunology, Vol. 22 No. 1 · 2023 · English · DOAJ Scopus

    Some risk causes may be associated with the severity of COVID-19. The central host-pathogen factors might affect infection are human receptor angiotensin-converting enzyme 2 (ACE2), trans-membrane protease serine 2 (TMPRSS2), and SARS-CoV-2 surface spike (S)-protein. The main purpose of this study…

  5. Journal Article

    Comparative Evaluation of Biochemical and Hematological Parameters of Pre-Storage Leukoreduction during RBC Storage

    Behrooz Ghezelbash; Azita Azarkeivan; Ali Akbar Pourfathollah et al.

    International Journal of Hematology-Oncology and Stem Cell Research, Vol. 12 No. 1 · 2018 · English · DOAJ Scopus

    Background: Some of the red cell storage lesions (RCSLs) take place during red blood cell (RBC) storage and may reduce the function of these cells dramatically, which mostly caused by residual leucocytes in blood components. This study was planned to observe the biochemical and hematological…

  6. Journal Article

    Differentially expressed inflammatory cell death-related genes and the serum levels of IL-6 are determinants for severity of coronaviruses diseases-2019 (COVID-19)

    Mohammad Heidarvand; Reza Hosseini; Mohammad Kazemi et al.

    Advanced Biomedical Research, Vol. 12 No. 1 · 2023 · English · DOAJ Scopus

    Background: Inflammatory cell death, PANoptosis, has been suggested to orchestrate the lymphocyte decrement among coronavirus disease-2019 (COVID-19) patients. The main aim of this study was to examine the differences in the expression of key genes related to inflammatory cell death and their…

  7. Journal Article

    PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia

    Mojdeh Soltani; Mustafa Ghanadian; Behrooz Ghezelbash et al.

    BMC Cancer, Vol. 23 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Background Leukemic cell metabolism plays significant roles in their proliferation and survival. These metabolic adaptations are under regulation by different factors. Programmed Death Ligand -1 (CD-274) is one of the immune checkpoint ligands that do not only cause the immune escape of…

  8. Journal Article

    Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective

    Narges Ebrahimi; Zahra Yousefi; Gholamreza Khosravi et al.

    Frontiers in Immunology, Vol. 14 · 2023 · English · DOAJ Scopus

    Human papillomavirus (HPV) is a viral infection that, if does not go away, can cause health problems like genital warts and cancer. The national immunization schedules for individuals before sexual debut, significantly decreased HPV-associated mortality and it will be affordable. However…

  9. Journal Article

    The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update

    Noushin Lotfi; Zahra Yousefi; Marjan Golabi et al.

    Frontiers in Immunology, Vol. 14 · 2023 · English · DOAJ Scopus

    Cancer is caused by abnormal proliferation of cells and aberrant recognition of the immune system. According to recent studies, natural products are most likely to be effective at preventing cancer without causing any noticeable complications. Among the bioactive flavonoids found in fruits and…

  10. Journal Article

    TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines

    Mahnaz Rezaei; Mustafa Ghanadian; Behrooz Ghezelbash et al.

    Frontiers in Immunology, Vol. 14 · 2023 · English · DOAJ Scopus

    IntroductionT-cell immunoglobulin and mucin domain-3 (TIM-3) is a transmembrane molecule first identified as an immunoregulator. This molecule is also expressed on leukemic cells in acute myeloid leukemia and master cell survival and proliferation. In this study, we aimed to explore the effect of…

  11. Journal Article

    Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities

    Hamed Fouladseresht; Atefe Ghamar Talepoor; Nahid Eskandari et al.

    Frontiers in Immunology, Vol. 12 · 2022 · English · DOAJ Scopus

    Although cellular and molecular mediators of the immune system have the potential to be prognostic indicators of disease outcomes, temporal interference between diseases might affect the immune mediators, and make them difficult to predict disease complications. Today one of the most important…

  12. Journal Article

    Circular RNAs: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia

    Atefe Rahmati; Alireza Mafi; Firooze Soleymani et al.

    Frontiers in Oncology, Vol. 13 · 2023 · English · DOAJ Scopus

    Acute myeloid leukemia (AML) is an aggressive hematological malignancy and affected patients have poor overall survival (OS) rates. Circular RNAs (circRNAs) are a novel class of non-coding RNAs (ncRNAs) with a unique loop structure. In recent years, with the development of high-throughput RNA…

  13. Journal Article

    A spotlight on the interplay between Wnt/β-catenin signaling and circular RNAs in hepatocellular carcinoma progression

    Alireza Mafi; Hamidreza Rismanchi; Mohaddese Malek Mohammadi et al.

    Frontiers in Oncology, Vol. 13 · 2023 · English · DOAJ Scopus

    Hepatocellular carcinoma (HCC) is one of the deadliest cancers due to multifocal development and distant metastasis resulting from late diagnosis. Consequently, new approaches to HCC diagnosis and treatment are required to reduce mortality rates. A large body of evidence suggests that non-coding…

  14. Journal Article

    Melatonin as a regulator of apoptosis in leukaemia: molecular mechanism and therapeutic perspectives

    Alireza Mafi; Hamidreza Rismanchi; Yasaman Gholinezhad et al.

    Frontiers in Pharmacology, Vol. 14 · 2023 · English · DOAJ Scopus

    Leukaemia is a dangerous malignancy that causes thousands of deaths every year throughout the world. The rate of morbidity and mortality is significant despite many advancements in therapy strategies for affected individuals. Most antitumour medications used now in clinical oncology use apoptotic…